At the start of infection (i.e., 3 d from the start of IL-13 treatment), goblet cells had increased in size and number in response to the cytokine (Figs. 4 A and B and 5 A and B and SI Appendix, Figs. S9 and S10). Here, IL13 is linked to infection.